Singapore markets closed

Teladoc Health, Inc. (0LDR.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
13.08-0.26 (-1.95%)
At close: 07:09PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-39.83%
S&P500 52-week change 322.36%
52-week high 330.38
52-week low 312.59
50-day moving average 318.78
200-day moving average 320.80

Share statistics

Avg vol (3-month) 319.44k
Avg vol (10-day) 318.28k
Shares outstanding 570.11M
Implied shares outstanding 6N/A
Float 8167.81M
% held by insiders 10.77%
% held by institutions 171.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -8.90%
Operating margin (ttm)-11.93%

Management effectiveness

Return on assets (ttm)-3.25%
Return on equity (ttm)-10.18%

Income statement

Revenue (ttm)2.62B
Revenue per share (ttm)15.80
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)N/A
EBITDA 60.3M
Net income avi to common (ttm)-233.03M
Diluted EPS (ttm)-43.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.1B
Total cash per share (mrq)6.49
Total debt (mrq)1.58B
Total debt/equity (mrq)69.01%
Current ratio (mrq)3.82
Book value per share (mrq)13.52

Cash flow statement

Operating cash flow (ttm)345.78M
Levered free cash flow (ttm)317.6M